Patent details

Basic Information

Publication number:

EP3738592

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP201832938

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

RAPAMYCIN FOR THE TREATMENT OF LYMPHANGIOLEIOMYOMATOSIS

French Title of Invention:

RAPAMYCINE POUR LE TRAITEMENT DE LA LYMPHANGIOLÉIOMYOMATOSE

German Title of Invention:

RAPAMYCIN ZUR BEHANDLUNG VON LYMPHANGIOLEIOMYOMATOSE

SPC Number:

Dates

Filing date:

07/10/2014

Grant date:

26/01/2022

EP Publication Date:

18/11/2020

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

26/01/2022

EP B1 Publication Date:

26/01/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

07/10/2022

Expiration date:

07/10/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/01/2022

 

 

Name:

AI Therapeutics, Inc.

Address:

530 Old Whitfield Street, Guilford, CT 06437, United States (US)

Inventor

1

Name:

ARMER, Thomas

Address:

United States (US)

2

Name:

LICHENSTEIN, Henri

Address:

United States (US)

3

Name:

MELVIN, Jr Lawrence S.

Address:

United States (US)

4

Name:

ROTHBERG, Jonathan, M.

Address:

United States (US)

Priority

Priority Number:

201361888066 P

Priority Date:

08/10/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/436; A61K 47/26; A61K 9/14; A61K 9/16;

Publication

European Patent Bulletin

Issue number:

202204

Publication date:

26/01/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages